NCT02466256

Brief Summary

This randomized clinical trial compares subjective performance during Intraocular lens (IOL) implantation, as well as incision enlargement and anterior segment morphology on OCT when IOL implantation was performed during microcoaxial phacoemulsification through a 2.2mm incision using one of three injectors : Manual screw type (Monarch III), Manual plunger type (Royale) and motorised injector (Autosert). Further, the investigators also looked at incision integrity by comparing ingress of trypan blue from the ocular surface into the anterior chamber.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 2, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 9, 2015

Completed
Last Updated

June 9, 2015

Status Verified

June 1, 2015

Enrollment Period

6 months

First QC Date

June 2, 2015

Last Update Submit

June 8, 2015

Conditions

Keywords

Intraocular lens implantation

Outcome Measures

Primary Outcomes (1)

  • Incision enlargement in mm

    1 minute after surgery

Secondary Outcomes (2)

  • Trypan Blue ingress into the anterior chamber in log units

    1 minute after surgery

  • Incision morphology - qualitative

    1 day, 1 week and 1 month after surgery

Study Arms (3)

Autosert Group

PLACEBO COMPARATOR

Procedure / Surgery : Intraocular lens implantation with Autosert injector

Procedure: Intraocular lens implantationDevice: Autosert Injector

Royale Group

PLACEBO COMPARATOR

Procedure / Surgery : Intraocular lens implantation with Royale Injector

Procedure: Intraocular lens implantationDevice: Royale Injector

Monarch III Injector

PLACEBO COMPARATOR

Procedure / Surgery : Intraocular lens implantation with Monarch III group

Device: Monarch III Injector

Interventions

Intraocular lens implantation

Autosert GroupRoyale Group

Motorised injection device for intraocular lens implantation

Autosert Group

Manual, plunger type injection device for intraocular lens implantation

Royale Group

Manual, screw type injection device for intraocular lens implantation

Monarch III Injector

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing phacoemulsification for age-related uncomplicated cataracts through a 2.2mm incision.
  • Nuclear or corticonuclear of grade 2 to 4 according to the Lens Opacities Classification System (LOCS III)

You may not qualify if:

  • Glaucoma,
  • uveitis,
  • shallow anterior chamber (depth \<2.1mm),
  • prior ocular trauma or surgery,
  • maximal pupillary dilatation \<6mm,
  • high myopia (axial length \>25mm),
  • posterior polar cataracts,
  • dense cataracts, and
  • an IOL power \<19.0 D or \>25.0 D

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cataract

Interventions

Lens Implantation, Intraocular

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • abhay r vasavada, ms, frcs

    iladevi cataract & iol research centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.S., F.R.C.S (England)

Study Record Dates

First Submitted

June 2, 2015

First Posted

June 9, 2015

Study Start

December 1, 2013

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

June 9, 2015

Record last verified: 2015-06